HighlightsEpiploic appendagitis can mimic acute cholecystitis and other common causes of abdominal pain.Epiploic appendagitis should be included in the differential of acute abdominal pain.Epiploic appendagitis is initially managed conservatively with analgesia and anti-inflammatories.
Lepidium sativum L. is one of the most important medicinal plants with many reported pharmacological activities. One of these activities is the antidiabetic activity which is not extensively studied. Therefore, this study aims at identifying the mechanism underlying L. sativum antidiabetic activity using network-based pharmacology and molecular docking. Network pharmacology analysis revealed that the hit antidiabetic constituents in L. sativum were quercetin, resveratrol, apigenin, luteolin, and linoleic acid. Whereas PPARA, PIK3CA, PIK3CB, AKT1, and GSK3B were the most enriched diabetes-related genes. In addition, the most significant diabetes-related pathways were metabolic pathways and insulin resistance. Molecular docking of hit L. sativum constituents on the most enriched diabetes-related genes' active sites demonstrated that the most stable interactions were possessed by quercetin. This study provides illustration of L. sativum molecular mechanisms for alleviation of diabetes and its complications for the first time through network pharmacology analysis accompanied with molecular docking and lays the foundation for future in vivo and clinical research.
El-Banna (2019) Serum sclerostin as a potential biomarker of vascular and valvular types of calcification in chronic kidney disease cases with and without maintenance hemodialysis,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.